Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meda AB Issues Q4 2013 EBITDA Guidance Below Analysts' Estimates; Issues Q4 2013 Organic Growth Guidance; Comments on FY 2013 Organic Growth Guidance-SIX


Friday, 8 Nov 2013 04:33am EST 

SIX reported that Meda AB expects an organic growth of approximately 7% in the fourth quarter of fiscal year 2013, which supports fiscal year 2013 forecast for organic growth of 3%. The EBITDA result for the fourth quarter of fiscal year 2013 is expected to be in line with the third quarter of fiscal year 2013. The Company reported EBITDA for the third quarter of 2013 of SEK 874 million. According to I/B/E/S estimates, analysts on average are expecting the Company to report EBITDA for the fourth quarter of 2013 of SEK 978.86 million. 

Company Quote

109.6
-1.0 -0.90%
23 Dec 2014